HAO vs GXC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HAO Captures Institutional Edge (2โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Haoxi Health Technology Limited Class A Ordinary Shares (HAO) driven by superior Growth & Margin, Momentum & Technical while GXC counters with relative strength in Options & Structure. Fundamentally, HAO trades at N/M Forward P/E with -14.9% operating margin (+137.3% YoY revenue) versus GXC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HAO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GXC sits in UNCLASSIFIED (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HAO | GXC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.3M | N/A | Larger Scale | HAO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +137.3% | N/A | Higher Growth | HAO |
| Operating Margin (TTM) Profitability | -14.9% | N/A | Higher Margin | HAO |
| Net Profit Margin Profitability | -17.4% | N/A | Higher Margin | HAO |
| Return on Equity (ROE) Capital Efficiency | -54.1% | N/A | Higher ROE | HAO |
| 52-Week Range Position Momentum | 36% ($0โ$5) | 0% ($80โ$105) | Stronger Trend | HAO |
| Beta / 30D Volatility Risk Regime | 7.50ฮฒ ยท 151% Vol | 0.65ฮฒ ยท 20% Vol | Lower Realized Risk | GXC |
| Unified Institutional Score Composite Signal | 55.9 / 100 (HOLD) | 39.5 / 100 (SELL) | Higher Composite | HAO |